Photo: Gaumard Scientific Despite medical and technological advancements, the United States has continued to face a maternal health crisis. In fact, the rate of maternal mortality has
People with higher genetic risk of clinical depression are more likely to have physical symptoms such as chronic pain, fatigue and migraine, University of Queensland researchers have found.
Novavax have announced the publication of results from the final analysis of its Phase 3 clinical trial of its COVID-19 vaccine (NVX-CoV2373), conducted in the UK and led
A report released this week by KLAS found that Arcadia, Epic and Innovaccer stand out when it comes to customer experience, market energy and breadth of population health
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of
A randomized double-blind controlled trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate
A study published in the Western Journal of Nursing Research found that patients using at-home monitoring systems for blood glucose and blood pressure levels received almost twice as
Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of
A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical
CAMBRIDGE, Mass.–(BUSINESS WIRE) December 5, 2020 — Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced new clinical data
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
